The Front Line COVID-19 Critical Care Alliance (FLCCC) is a group of physicians and former journalists formed in April 2020 that has advocated for various unapproved, dubious, and/or ineffective treatments (e.g. hydroxychloroquine, ivermectin, and other miscellaneous combinations of drugs and vitamins) for COVID-19. The group is led by Paul E. Marik and Pierre Kory. Both would later join conservative or right-wing groups promoting COVID-19 vaccine hesitancy and misinformation.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Front Line COVID-19 Critical Care Alliance (en)
|
rdfs:comment
| - The Front Line COVID-19 Critical Care Alliance (FLCCC) is a group of physicians and former journalists formed in April 2020 that has advocated for various unapproved, dubious, and/or ineffective treatments (e.g. hydroxychloroquine, ivermectin, and other miscellaneous combinations of drugs and vitamins) for COVID-19. The group is led by Paul E. Marik and Pierre Kory. Both would later join conservative or right-wing groups promoting COVID-19 vaccine hesitancy and misinformation. (en)
|
differentFrom
| |
foaf:homepage
| |
name
| - Front Line COVID-19 Critical Care Alliance (en)
|
dct:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
abbreviation
| |
formation
| |
leader name
| |
leader title
| |
website
| |
has abstract
| - The Front Line COVID-19 Critical Care Alliance (FLCCC) is a group of physicians and former journalists formed in April 2020 that has advocated for various unapproved, dubious, and/or ineffective treatments (e.g. hydroxychloroquine, ivermectin, and other miscellaneous combinations of drugs and vitamins) for COVID-19. The group is led by Paul E. Marik and Pierre Kory. Both would later join conservative or right-wing groups promoting COVID-19 vaccine hesitancy and misinformation. The World Health Organization, U.S. Food and Drug Administration, and European Medicines Agency advise against the use of ivermectin for COVID-19 outside of clinical trials, but the FLCCC has contended that ivermectin could reduce viral load and accelerate recovery in patients. (en)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is differentFrom
of | |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is Wikipage disambiguates
of | |
is work institutions
of | |
is institution
of | |
is foaf:primaryTopic
of | |